Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Usefulness of Early Warning Systems in Detecting Early Clinical Deterioration After Intensive Care Discharge

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03910777
Recruitment Status : Unknown
Verified July 2019 by ILKE KUPELI, Erzincan University.
Recruitment status was:  Recruiting
First Posted : April 10, 2019
Last Update Posted : July 17, 2019
Sponsor:
Information provided by (Responsible Party):
ILKE KUPELI, Erzincan University

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

The VitalPac Early Warning Score (VIEWS) scoring system, developed by Prytherch et al., Is an early warning system that aims to predict the first 24-hour mortality in emergency patients.

National early warning score (NEWS) is another early warning scoring system recommended by the Royal College of Physicians in London to detect early clinical deterioration in hospitalized patients.

The aim of this study was to determine the early clinical deterioration after ICU and hence the rate of admission to intensive care and to evaluate whether these two scoring systems can be used to determine early clinical deterioration in intensive care early discharge.


Condition or disease Intervention/treatment
Early Clinical Deterioration Early Warning Score Diagnostic Test: Early Warning Score

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 390 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 6 Months
Official Title: Usefulness of Early Warning Systems in Detecting Early Clinical Deterioration After Intensive Care Discharge
Estimated Study Start Date : August 1, 2019
Estimated Primary Completion Date : January 1, 2020
Estimated Study Completion Date : January 15, 2020
Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Intervention Details:
  • Diagnostic Test: Early Warning Score
    National early warning score (NEWS) is another early warning scoring system recommended by the Royal College of Physicians in London to detect early clinical deterioration in hospitalized patients

Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Number of patients recovered due to early clinical deterioration within the first 24 hours after ICU discharge [ Time Frame: six month ]
    The aim of this study is to determine the early clinical deterioration in the first 24 hours after ICU discharge and therefore the rate of admission to ICU.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
390 patients who were discharged from the intensive care unit over the age of 18 and who were taken back within 24 hours will be included.
Criteria

Inclusion Criteria:

  • over 18 years,
  • discharged from the ICU and returned within 24 hours

Exclusion Criteria:

  • under 18 years old, postoperative patients, pregnant women
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03910777


Contacts
Layout table for location contacts
Contact: ilke kupeli +905555485632 ilkeser2004@gmail.com

Locations
Layout table for location information
Turkey
Erzincan University Recruiting
Erzincan, Turkey, 24100
Contact: ufuk kuyrukluyıldız    +904462122222    drufuk2001@gmail.com   
Principal Investigator: ilke kupeli         
Sponsors and Collaborators
Erzincan University
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Additional Information:

Publications of Results:

Layout table for additonal information
Responsible Party: ILKE KUPELI, assist. prof., Erzincan University
ClinicalTrials.gov Identifier: NCT03910777    
Other Study ID Numbers: EBYU 2
First Posted: April 10, 2019    Key Record Dates
Last Update Posted: July 17, 2019
Last Verified: July 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Clinical Deterioration
Disease Progression
Disease Attributes
Pathologic Processes